(Q31169591)

English

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT) (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

psoriatic arthritis

1 reference

based on heuristic

inferred from title

Dafna D. Gladman

12

object named as

D D Gladman

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

P J Mease

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

P Ory

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

J T Sharp

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

C T Ritchlin

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

F Van den Bosch

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

F Wellborne

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

C Birbara

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

G T D Thomson

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

R J Perdok

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

J Medich

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

R L Wong

11

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

6 August 2008

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

68

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

702-709

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Psoriasis: epidemiology, clinical features, and quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Longitudinal study of clinical and radiological progression in psoriatic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

21 June 2018

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

31 October 2018

Translating the science of quality of life into practice: What do dermatology life quality index scores mean?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

31 October 2018

Employment across chronic inflammatory rheumatic diseases and comparison with the general population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

31 October 2018

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

31 October 2018

The direct cost of care for psoriasis and psoriatic arthritis in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

31 October 2018

Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663711

31 October 2018

Psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psoriatic arthritis (PSA)--an analysis of 220 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-term use of azathioprine in patients with psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of sulfasalazine in psoriatic arthritis: a clinic experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18684743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2008.092767

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31169591&oldid=1637367440"